Eczema affects more people in the United States than diabetes (10.1 vs. 9.4 million)1,2. More than […]
In our rescue white paper, 3 Measures to Overcome Operational Failures, we explain our ROI concept. Early in a trial, intervention provides dramatic benefits for minimal cost. An assessment or review may be all that’s needed to get a study back on track.
Less than a year ago, FDA approved the first cannabinoid-derived drug, Epidiolex. It’s a […]
Each year, doctors diagnose about 1,000 Americans with cystic fibrosis, a rare hereditary disease that affects […]
“Microbiome” has become a consumer product buzzword, found in advertisements for soap and dozens […]